Table of Content

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. Huntington`s Disease Therapeutics Market, by Region

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increase in need for drugs to control Huntington’s disease symptoms
5.1.1.2. Rising government initiatives to increase awareness about Huntington’s disease
5.1.2. Restraints
5.1.2.1. High cost associated with advanced treatments
5.1.3. Opportunities
5.1.3.1. Increase in clinical research activities for drug development for Huntington’s disease
5.1.3.2. Growing drug approvals for the treatment of Huntington’s disease patients
5.1.4. Challenges
5.1.4.1. Problems associated with strict regulatory policies for development of Huntington’s disease drugs
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Huntington`s Disease Therapeutics Market, by Type
6.1. Introduction
6.2. Disease-modifying Therapies
6.3. Gene Therapies
6.4. Medication
6.5. Occupational Therapies
6.6. Symptomatic Treatment

7. Huntington`s Disease Therapeutics Market, by End-User
7.1. Introduction
7.2. Hospitals
7.3. Long-Term Care Facilities
7.4. Specialty Clinics

8. Americas Huntington`s Disease Therapeutics Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Huntington`s Disease Therapeutics Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Huntington`s Disease Therapeutics Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio
12.1. Key Company Profiles
12.1.1. Alnylam Pharmaceuticals, Inc.
12.1.2. Alterity Therapeutics Limited
12.1.3. Annexon Biosciences
12.1.4. AOP Orphan Pharmaceuticals GmbH
12.1.5. Bausch Health Companies Inc.
12.1.6. Dr. Reddy’s Laboratories Ltd.
12.1.7. Hikma Pharmaceuticals PLC
12.1.8. Ionis Pharmaceuticals Inc.
12.1.9. Ipsen S.A.
12.1.10. Lupin Limited
12.1.11. Medesis Pharma SA
12.1.12. Mitochon Pharmaceuticals, Inc.
12.1.13. NeuExcell Therapeutics Inc
12.1.14. Neurocrine Biosciences, Inc.
12.1.15. Novartis AG
12.1.16. Pfizer Inc.
12.1.17. Prilenia Therapeutics B.V.
12.1.18. PTC Therapeutics Inc.
12.1.19. SOM Innovation Biotech S.A.
12.1.20. Sun Pharmaceutical Industries Limited
12.1.21. Teva Pharmaceutical Industries Ltd.
12.1.22. uniQure N.V.
12.1.23. Vaccinex Inc.
12.1.24. Vertex Pharmaceuticals Incorporated
12.2. Key Product Portfolio

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing



List of Figures

FIGURE 1. HUNTINGTON`S DISEASE THERAPEUTICS MARKET RESEARCH PROCESS
FIGURE 2. HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, 2023 VS 2030
FIGURE 3. HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. HUNTINGTON`S DISEASE THERAPEUTICS MARKET DYNAMICS
FIGURE 7. HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 10. HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 12. AMERICAS HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 14. UNITED STATES HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. HUNTINGTON`S DISEASE THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 20. HUNTINGTON`S DISEASE THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. HUNTINGTON`S DISEASE THERAPEUTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2023
TABLE 3. HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 6. HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY DISEASE-MODIFYING THERAPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY GENE THERAPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY MEDICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY OCCUPATIONAL THERAPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY SYMPTOMATIC TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 12. HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY LONG-TERM CARE FACILITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. AMERICAS HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 16. AMERICAS HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 17. AMERICAS HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 18. ARGENTINA HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 19. ARGENTINA HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 20. BRAZIL HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 21. BRAZIL HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 22. CANADA HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 23. CANADA HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 24. MEXICO HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 25. MEXICO HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 26. UNITED STATES HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 27. UNITED STATES HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 28. UNITED STATES HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 29. ASIA-PACIFIC HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 30. ASIA-PACIFIC HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 31. ASIA-PACIFIC HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 32. AUSTRALIA HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 33. AUSTRALIA HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 34. CHINA HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 35. CHINA HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 36. INDIA HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 37. INDIA HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 38. INDONESIA HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 39. INDONESIA HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 40. JAPAN HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 41. JAPAN HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 42. MALAYSIA HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 43. MALAYSIA HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 44. PHILIPPINES HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 45. PHILIPPINES HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 46. SINGAPORE HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 47. SINGAPORE HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 48. SOUTH KOREA HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 49. SOUTH KOREA HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 50. TAIWAN HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 51. TAIWAN HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 52. THAILAND HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 53. THAILAND HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 54. VIETNAM HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 55. VIETNAM HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 56. EUROPE, MIDDLE EAST & AFRICA HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 57. EUROPE, MIDDLE EAST & AFRICA HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 58. EUROPE, MIDDLE EAST & AFRICA HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 59. DENMARK HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 60. DENMARK HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 61. EGYPT HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 62. EGYPT HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 63. FINLAND HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 64. FINLAND HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 65. FRANCE HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 66. FRANCE HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 67. GERMANY HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 68. GERMANY HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 69. ISRAEL HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 70. ISRAEL HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 71. ITALY HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 72. ITALY HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 73. NETHERLANDS HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 74. NETHERLANDS HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 75. NIGERIA HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 76. NIGERIA HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 77. NORWAY HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 78. NORWAY HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 79. POLAND HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 80. POLAND HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 81. QATAR HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 82. QATAR HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 83. RUSSIA HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 84. RUSSIA HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 85. SAUDI ARABIA HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 86. SAUDI ARABIA HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 87. SOUTH AFRICA HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 88. SOUTH AFRICA HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 89. SPAIN HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 90. SPAIN HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 91. SWEDEN HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 92. SWEDEN HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 93. SWITZERLAND HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 94. SWITZERLAND HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 95. TURKEY HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 96. TURKEY HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 97. UNITED ARAB EMIRATES HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 98. UNITED ARAB EMIRATES HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 99. UNITED KINGDOM HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 100. UNITED KINGDOM HUNTINGTON`S DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 101. HUNTINGTON`S DISEASE THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 102. HUNTINGTON`S DISEASE THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 103. HUNTINGTON`S DISEASE THERAPEUTICS MARKET LICENSE & PRICING